A. Fowles

发表

The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer

I. Holen, P. Croucher, Ning Wang, 2015, Journal of experimental & clinical cancer research : CR.

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

I. Holen, E. Waterman, N. Cross, 2008, Journal of cellular biochemistry.

Imaging the effects of castration on bone turnover and hormone‐independent prostate cancer colonization of bone

I. Holen, N. Cross, C. Eaton, 2008, The Prostate.

The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells

M. Cecchini, C. Eaton, F. Ahmed, 2018, Biotechnology and applied biochemistry.

THE EFFECT OF RADIOIODINE AND ANTITHYROID DRUGS ON SERUM LONG ACTING THYROID STIMULATOR PROTECTOR (LATS‐P). A THREE YEAR PROSPECTIVE STUDY

C. Hardisty, D. Munro, A. Fowles, 1984, Clinical endocrinology.

Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancer

I. Holen, P. Croucher, Ning Wang, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves’ disease associated with localized myxedema

C. Hardisty, D. Munro, A. Fowles, 1984, Journal of endocrinological investigation.

Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo

I. Holen, C. Eaton, F. Nutter, 2016, Clinical & Experimental Metastasis.

Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo

I. Holen, C. Evans, C. Eaton, 2015, Clinical & Experimental Metastasis.

The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer

I. Holen, P. Croucher, Ning Wang, 2015, Journal of experimental & clinical cancer research : CR.

The expression and regulation of ADAMTS‐1, ‐4, ‐5, ‐9, and ‐15, and TIMP‐3 by TGFβ1 in prostate cells: relevance to the accumulation of versican

F. Hamdy, N. Cross, C. Eaton, 2005, The Prostate.

Abstract PD07-08: Zoledronic acid specifically inhibits development of bone metastases in the post-menopausal setting – evidence from an in vivo breast cancer model

I. Holen, P. Croucher, Ning Wang, 2012 .

RUNX/CBFβ transcription factor complexes promote the phenotypic plasticity of metastatic breast cancer cells

I. Holen, A. Mastro, H. Harrison, 2019, bioRxiv.